Status: Not yet recruiting
To Evaluate Efficacy and Safety of TopicalKX-826 Solution in Chinese Male Patients With Androgenetic Alopecia
This study is a multicenter, randomized, double-blind, vehicle controlled, adaptive design phase 2/3 study to evaluate the efficacy and safety of topical KX-826 solution in Chinese male patients with androgenetic alopecia (AGA). It consisted of two phases, phase 2 dose exploration trial and phase 3 confirmatory trial.
Participants needed: 756
Trial details
Phase: Phase 2, Phase 3Age: 18-49Biological sex: MaleType: InterventionalSponsor: Suzhou Kintor Pharmaceutical Inc,Updated: Oct 21, 2024Locations: 1
Eligibility criteria
Agree to comply with study procedures and visit plan. Subject is capable of givi... [+5]
Had a history or active hair loss due to diffuse telogen effluvium, alopecia are... [+39]